Hyperglycemic kidney damage in an animal model of prolonged critical illness

Kidney International

Volumn 76, Issue 5, 2009, Pages 512-520

  Vanhorebeek, Ilse ^a   Gunst, Jan ^a   Ellger, Björn ^a,c   Boussemaere, Magaly ^a   Lerut, Evelyne ^a   Debaveye, Yves ^a,d   Rabbani, Naila ^b   Thornalley, Paul J ^b   Schetz, Miet ^a   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d Europe Hospitals   (Belgium)

Author keywords

Acute kidney injury; Critical illness; Hyperglycemia; Insulin; Mitochondria; Oxygen delivery

Indexed keywords

CREATININE; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GLUCOSE MONITORING; BURN; CELL DAMAGE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY PERFUSION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN SUPPLY; PRIORITY JOURNAL; RABBIT; RENAL PROTECTION;

ANIMALS; BLOOD GLUCOSE; CREATININE; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; GLUCOSE; GLYCOLYSIS; GLYOXAL; HYPERGLYCEMIA; INSULIN; KIDNEY; MALE; MITOCHONDRIA; OXYGEN; RABBITS;

EID: 68949206301     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.217     Document Type: Article

References (60)

1. Bellomo R, Ronco C, Kellum JA, et al., the ADQI workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
2. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417-430.
3. Uchino S, Kellum JA, Bellomo R, et al., for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients. A multinational, multicenter study. JAMA 2005; 294: 813-818.
4. Kellum JA, Leblanc M, Gibney RTN et al. Primary prevention of acute renal failure in the critically ill. Curr Opin Crit Care 2005; 11: 537-541.
5. Hoste EAJ, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10: R73.
6. Leblanc M, Kellum JA, Gibney RTM et al. Risk factors for acute renal failure: inherent and modifiable risks. Curr Opin Crit Care 2005; 11: 533-536.
7. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367.
8. Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in medical intensive care patients. N Engl J Med 2006; 354: 449-461.
9. Van den Berghe G, Wilmer A, Milants I et al. Intensive insulin therapy in mixed medical/surgical intensive care units. Benefit versus harm. Diabetes 2006; 55: 3151-3159.
10. Schetz M, Vanhorebeek I, Wouters PJ et al. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 2008; 19: 571-578.
11. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007; 132: 268-278.
12. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000.
13. Treggiari MM, Karir V, Yanez ND et al. Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008; 12: R29.
14. Lecomte P, Van Vlem B, Coddens J et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care 2008; 12: R154.
15. Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139.
16. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2004; 164: 2005-2011.
17. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300: 933-944.
18. Griesdale DEG, de Souza RJ, van Dam RM et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180: 821-827.
19. Finfer S, Chittock DR, Su SY et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
20. Inzucchi SE, Siegel MD. Glucose control in the ICU - how tight is too tight? N Engl J Med 2009; 360: 1346-1349.
21. Van den Berghe G, Mesotten D, Vanhorebeek I. Intensive insulin therapy in the intensive care unit. CMAJ 2009; 180: 799-800.
22. Hall AM, Unwin RJ. The not so 'mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiol 2007; 105: 1-10.
23. Langouche L, Vanhorebeek I, Vlasselaers D et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115: 2277-2286.
24. Vanhorebeek I, De Vos R, Mesotten D et al. Protection of hepatocyte ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365: 53-59.
25. Ellger B, Debaveye Y, Vanhorebeek I et al. Survival benefits of intensive insulin therapy in critical illness. Impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006; 55: 1096-1105.
26. Partridge GG, Lobley GE, Fordyce RA. Energy and nitrogen metabolism of rabbits during pregnancy, lactation, and concurrent pregnancy and lactation. Br J Nutr 1986; 56: 199-207.
27. Weekers F, Giulietti A-P, Michalaki M et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003; 144: 5329-5338.
28. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520.
29. Epstein FH, Agmon Y, Brezis M. Physiology of renal hypoxia. Ann NY Acad Sci 1994; 718: 72-81.
30. Van den Berghe G, Wouters PJ, Bouillon R et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366.
31. O'Connor PM. Renal oxygen delivery: matching delivery to metabolic demand. Clin Exp Pharm Physiol 2006; 33: 961-967.
32. Ogawa Y, Matsumoto K, Ofuji S. Changes in adenine nucleotide and mitochondrial metabolism of the kidney of burned rats and their relation to insulin. J Lab Clin Med 1977; 90: 457-465.
33. Mela L, Miller LD. Efficacy of glucocorticoids in preventing mitochondrial metabolic failure in endotoxemia. Circ Shock 1983; 10: 371-381.
34. Singer M, Brealey D. Mitochondrial dysfunction in sepsis. Biochem Soc Symp 1999; 66: 149-166.
35. Crouser ED, Julian MW, Dorinsky PM. Ileal VO2-DO2 alterations induced by endotoxin correlate with the severity of mitochondrial injury. Am J Resp Crit Care Med 1999; 160: 1347-1353.
36. Brealey D, Brand M, Hargreaves I et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360: 219-223.
37. Crouser ED, Julian MW, Blaho DV et al. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002; 30: 276-284.
38. Brealey D, Karyampudi S, Jacques TS et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286: R491-R497.
39. Fink MP. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001; 17: 219-237.
40. Thornalley PJ. Dicarbonyl intermediates in the Maillard reaction. Ann NY Acad Sci 2005; 1043: 111-117.
41. Beisswenger PJ, Howell SK, O'Dell RM et al. Alpha-dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diab Care 2001; 24: 726-732.
42. Berlanga J, Cibrian D, Guillén I et al. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci 2005; 109: 83-95.
43. Shangari N, Bruce WR, Poon R et al. Toxicity of glyoxals - role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochem Soc Trans 2003; 31: 1390-1393.
44. Shangari N, O'Brien PJ. The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem Pharmacol 2004; 68: 1433-1442.
45. Rosca MG, Monnier VM, Szweda LI et al. Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. Am J Physiol Renal Physiol 2002; 283: F52-F59.
46. Rosca MG, Mustata TG, Kinter MT et al. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol 2005; 289: F420-F430.
47. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
48. Thornalley PJ. Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J 1988; 254: 751-755.
49. Gore DC, Jahoor F, Hibbert JM et al. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996; 224: 97-102.
50. Revelly J-P, Tappy L, Martinez A et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med 2005; 33: 2235-2240.
51. Weekers F, Van Herck E, Coopmans W et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology 2002; 143: 764-774.
52. L'Her E, Sebert P. A global approach to energy metabolism in an experimental model of sepsis. Am J Respir Crit Care Med 2001; 164: 1444-1447.
53. Wang P, Lloyg SG, Chatham JC. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart. Circulation 2005; 111: 2066-2072.
54. Lazar HL, Chipkin SR, Fitzgerald CA et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497-1502.
55. Wieland W, Wouters PF, Van Aken H et al. Measurement of organ blood flow with coloured microspheres: a first time-saving improvement using automated spectrophotometry. Proc Comp Cardiol 1993: 691-694.
56. Langouche L, Vander Perre S, Wouters PJ et al. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab 2007; 92: 3890-3897.
57. Bergmeyer HU (ed). Methods of Enzymatic Analysis. Verlag Chemie: Weinheim, Germany, 1985.
58. Akerboom TPM, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 1981; 77: 373-382.
59. McLellan AC, Thornalley PJ. Sample storage conditions for the assay of glyoxalase activities in whole blood samples. Ann Clin Biochem 1992; 29: 222-223.
60. Dobler D, Ahmed N, Song L et al. Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 2006; 55: 1961-1969.